HEADER ISOMERASE 25-JAN-07 2OOH TITLE CRYSTAL STRUCTURE OF MIF BOUND TO A NOVEL INHIBITOR, OXIM-11 COMPND MOL_ID: 1; COMPND 2 MOLECULE: MACROPHAGE MIGRATION INHIBITORY FACTOR; COMPND 3 CHAIN: A, B, C; COMPND 4 SYNONYM: MIF, PHENYLPYRUVATE TAUTOMERASE, GLYCOSYLATION-INHIBITING COMPND 5 FACTOR, GIF, (EC 5.3.2.1); COMPND 6 EC: 5.3.2.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MIF; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET11B KEYWDS ALTERNATIVE LIGAND-BINDING MODES, ISOMERASE EXPDTA X-RAY DIFFRACTION AUTHOR G.V.CRICHLOW,Y.AL-ABED,E.LOLIS REVDAT 6 30-AUG-23 2OOH 1 REMARK REVDAT 5 18-OCT-17 2OOH 1 REMARK REVDAT 4 13-JUL-11 2OOH 1 VERSN REVDAT 3 24-FEB-09 2OOH 1 VERSN REVDAT 2 12-FEB-08 2OOH 1 JRNL REVDAT 1 05-JUN-07 2OOH 0 JRNL AUTH G.V.CRICHLOW,K.F.CHENG,D.DABIDEEN,M.OCHANI,B.ALJABARI, JRNL AUTH 2 V.A.PAVLOV,E.J.MILLER,E.LOLIS,Y.AL-ABED JRNL TITL ALTERNATIVE CHEMICAL MODIFICATIONS REVERSE THE BINDING JRNL TITL 2 ORIENTATION OF A PHARMACOPHORE SCAFFOLD IN THE ACTIVE SITE JRNL TITL 3 OF MACROPHAGE MIGRATION INHIBITORY FACTOR. JRNL REF J.BIOL.CHEM. V. 282 23089 2007 JRNL REFN ISSN 0021-9258 JRNL PMID 17526494 JRNL DOI 10.1074/JBC.M701825200 REMARK 2 REMARK 2 RESOLUTION. 1.85 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.85 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 110.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 95.1 REMARK 3 NUMBER OF REFLECTIONS : 44612 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT, UNTIL MOST OF THE REMARK 3 MODEL WAS COMPLETED, THEN ALL REMARK 3 OBSERVED DATA WERE USED IN REMARK 3 SOME OF THE LATER REFINEMENT REMARK 3 ROUNDS. (R-FREE VALUE QUOTED REMARK 3 IS THAT OBTAINED BEFORE REMARK 3 REFINEMENT WAS PERFORMED REMARK 3 AGAINST ALL DATA). REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.191 REMARK 3 FREE R VALUE : 0.218 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 2228 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2586 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 88 REMARK 3 SOLVENT ATOMS : 305 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 22.76 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : ISOTROPIC REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: OXIM-11 MOLECULES WERE MODELLED WITH REMARK 3 PARTIAL OCCUPANCIES. GLYCEROL MOLECULES MODELLED IN THE SAME REMARK 3 ACTIVE SITES AS OXIM-11 HAVE OCCUPANCIES WERE MODLLED AS HAVING REMARK 3 OCCUPANCIES EQUAL TO 1-(OXIM-11 OCCUPANCY FOR THAT ACTIVE SITE). REMARK 3 THE RATIO OF OXIM-11 TO GLYCEROL OCCUPANCY FOR EACH ACTIVE SITE REMARK 3 WAS DETERMINED BY OCCUPANCY REFINEMENT IN CNS REMARK 4 REMARK 4 2OOH COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 22-FEB-07. REMARK 100 THE DEPOSITION ID IS D_1000041389. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-JAN-06 REMARK 200 TEMPERATURE (KELVIN) : 93 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO, HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK, HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 46128 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.850 REMARK 200 RESOLUTION RANGE LOW (A) : 110.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.2 REMARK 200 DATA REDUNDANCY : 4.600 REMARK 200 R MERGE (I) : 0.06100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 20.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.85 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.92 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.0 REMARK 200 DATA REDUNDANCY IN SHELL : 4.00 REMARK 200 R MERGE FOR SHELL (I) : 0.35000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1LJT REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 66.45 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.67 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 50% SATURATED AMMONIUM SULFATE, 4% REMARK 280 ISOPROPANOL, 0.1 M TRIS(HYDROXYMETHYL)AMINOMETHANE,MIXED WITH REMARK 280 PROTEIN:INHIBITOR COMPLEX IN A 1:1 RATIO, PH 7.5, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 296K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 34.36400 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 68.72800 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 68.72800 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 34.36400 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE ASYMMETRIC UNIT CONTAINS ONE HOMOTRIMER OF MIF, WHICH REMARK 300 IS PRESUMED TO BE THRE BIOLOGICAL UNIT. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 9760 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12820 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -136.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 88 NE CZ NH1 NH2 REMARK 470 ARG B 11 CD NE CZ NH1 NH2 REMARK 470 LYS B 66 CE NZ REMARK 470 LYS B 77 CE NZ REMARK 470 LYS C 66 CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 111 -158.98 -145.27 REMARK 500 SER B 111 -158.81 -147.44 REMARK 500 ASN C 109 74.50 37.93 REMARK 500 SER C 111 -163.24 -170.38 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 901 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 905 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 906 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 907 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 908 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 902 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 904 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 C 903 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE OX3 B 200 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE OX3 C 200 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL C 701 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL C 702 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2OOW RELATED DB: PDB REMARK 900 RELATED ID: 2OOZ RELATED DB: PDB DBREF 2OOH A 1 114 UNP P14174 MIF_HUMAN 1 114 DBREF 2OOH B 1 114 UNP P14174 MIF_HUMAN 1 114 DBREF 2OOH C 1 114 UNP P14174 MIF_HUMAN 1 114 SEQRES 1 A 114 PRO MET PHE ILE VAL ASN THR ASN VAL PRO ARG ALA SER SEQRES 2 A 114 VAL PRO ASP GLY PHE LEU SER GLU LEU THR GLN GLN LEU SEQRES 3 A 114 ALA GLN ALA THR GLY LYS PRO PRO GLN TYR ILE ALA VAL SEQRES 4 A 114 HIS VAL VAL PRO ASP GLN LEU MET ALA PHE GLY GLY SER SEQRES 5 A 114 SER GLU PRO CYS ALA LEU CYS SER LEU HIS SER ILE GLY SEQRES 6 A 114 LYS ILE GLY GLY ALA GLN ASN ARG SER TYR SER LYS LEU SEQRES 7 A 114 LEU CYS GLY LEU LEU ALA GLU ARG LEU ARG ILE SER PRO SEQRES 8 A 114 ASP ARG VAL TYR ILE ASN TYR TYR ASP MET ASN ALA ALA SEQRES 9 A 114 ASN VAL GLY TRP ASN ASN SER THR PHE ALA SEQRES 1 B 114 PRO MET PHE ILE VAL ASN THR ASN VAL PRO ARG ALA SER SEQRES 2 B 114 VAL PRO ASP GLY PHE LEU SER GLU LEU THR GLN GLN LEU SEQRES 3 B 114 ALA GLN ALA THR GLY LYS PRO PRO GLN TYR ILE ALA VAL SEQRES 4 B 114 HIS VAL VAL PRO ASP GLN LEU MET ALA PHE GLY GLY SER SEQRES 5 B 114 SER GLU PRO CYS ALA LEU CYS SER LEU HIS SER ILE GLY SEQRES 6 B 114 LYS ILE GLY GLY ALA GLN ASN ARG SER TYR SER LYS LEU SEQRES 7 B 114 LEU CYS GLY LEU LEU ALA GLU ARG LEU ARG ILE SER PRO SEQRES 8 B 114 ASP ARG VAL TYR ILE ASN TYR TYR ASP MET ASN ALA ALA SEQRES 9 B 114 ASN VAL GLY TRP ASN ASN SER THR PHE ALA SEQRES 1 C 114 PRO MET PHE ILE VAL ASN THR ASN VAL PRO ARG ALA SER SEQRES 2 C 114 VAL PRO ASP GLY PHE LEU SER GLU LEU THR GLN GLN LEU SEQRES 3 C 114 ALA GLN ALA THR GLY LYS PRO PRO GLN TYR ILE ALA VAL SEQRES 4 C 114 HIS VAL VAL PRO ASP GLN LEU MET ALA PHE GLY GLY SER SEQRES 5 C 114 SER GLU PRO CYS ALA LEU CYS SER LEU HIS SER ILE GLY SEQRES 6 C 114 LYS ILE GLY GLY ALA GLN ASN ARG SER TYR SER LYS LEU SEQRES 7 C 114 LEU CYS GLY LEU LEU ALA GLU ARG LEU ARG ILE SER PRO SEQRES 8 C 114 ASP ARG VAL TYR ILE ASN TYR TYR ASP MET ASN ALA ALA SEQRES 9 C 114 ASN VAL GLY TRP ASN ASN SER THR PHE ALA HET SO4 A 901 5 HET SO4 A 905 5 HET SO4 A 906 5 HET SO4 A 907 5 HET SO4 A 908 5 HET SO4 B 902 5 HET SO4 B 904 5 HET OX3 B 200 18 HET SO4 C 903 5 HET OX3 C 200 18 HET GOL C 701 6 HET GOL C 702 6 HETNAM SO4 SULFATE ION HETNAM OX3 4-HYDROXYBENZALDEHYDE O-(CYCLOHEXYLCARBONYL)OXIME HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 4 SO4 8(O4 S 2-) FORMUL 11 OX3 2(C14 H17 N O3) FORMUL 14 GOL 2(C3 H8 O3) FORMUL 16 HOH *305(H2 O) HELIX 1 1 PRO A 10 VAL A 14 5 5 HELIX 2 2 GLY A 17 GLY A 31 1 15 HELIX 3 3 PRO A 33 TYR A 36 5 4 HELIX 4 4 GLY A 68 ARG A 88 1 21 HELIX 5 5 SER A 90 ASP A 92 5 3 HELIX 6 6 ASN A 102 ALA A 104 5 3 HELIX 7 7 PRO B 10 VAL B 14 5 5 HELIX 8 8 GLY B 17 GLY B 31 1 15 HELIX 9 9 PRO B 33 TYR B 36 5 4 HELIX 10 10 GLY B 68 ARG B 88 1 21 HELIX 11 11 SER B 90 ASP B 92 5 3 HELIX 12 12 ASN B 102 ALA B 104 5 3 HELIX 13 13 PRO C 10 VAL C 14 5 5 HELIX 14 14 GLY C 17 GLY C 31 1 15 HELIX 15 15 PRO C 33 TYR C 36 5 4 HELIX 16 16 GLY C 68 ARG C 88 1 21 HELIX 17 17 SER C 90 ASP C 92 5 3 HELIX 18 18 ASN C 102 ALA C 104 5 3 SHEET 1 A 7 LEU B 46 PHE B 49 0 SHEET 2 A 7 ALA A 38 VAL A 42 -1 N VAL A 39 O ALA B 48 SHEET 3 A 7 MET A 2 THR A 7 1 N VAL A 5 O VAL A 42 SHEET 4 A 7 ALA A 57 SER A 63 -1 O HIS A 62 N MET A 2 SHEET 5 A 7 VAL A 94 ASP A 100 1 O TYR A 95 N CYS A 59 SHEET 6 A 7 VAL C 106 TRP C 108 -1 O GLY C 107 N ILE A 96 SHEET 7 A 7 SER C 111 THR C 112 -1 O SER C 111 N TRP C 108 SHEET 1 B 7 LEU A 46 PHE A 49 0 SHEET 2 B 7 ALA C 38 VAL C 42 -1 O VAL C 41 N LEU A 46 SHEET 3 B 7 MET C 2 THR C 7 1 N VAL C 5 O VAL C 42 SHEET 4 B 7 ALA C 57 SER C 63 -1 O HIS C 62 N MET C 2 SHEET 5 B 7 VAL C 94 ASP C 100 1 O TYR C 95 N CYS C 59 SHEET 6 B 7 VAL B 106 TRP B 108 -1 N GLY B 107 O ILE C 96 SHEET 7 B 7 SER B 111 THR B 112 -1 O SER B 111 N TRP B 108 SHEET 1 C 7 SER A 111 THR A 112 0 SHEET 2 C 7 VAL A 106 TRP A 108 -1 N TRP A 108 O SER A 111 SHEET 3 C 7 VAL B 94 ASP B 100 -1 O ILE B 96 N GLY A 107 SHEET 4 C 7 ALA B 57 SER B 63 1 N CYS B 59 O TYR B 95 SHEET 5 C 7 MET B 2 THR B 7 -1 N MET B 2 O HIS B 62 SHEET 6 C 7 ALA B 38 VAL B 42 1 O VAL B 42 N VAL B 5 SHEET 7 C 7 LEU C 46 PHE C 49 -1 O LEU C 46 N VAL B 41 SITE 1 AC1 5 GLY A 68 GLY A 69 ALA A 70 GLN A 71 SITE 2 AC1 5 HOH A 400 SITE 1 AC2 6 ARG A 73 HOH A 232 HOH A 422 PRO B 15 SITE 2 AC2 6 ASP B 16 HOH C 453 SITE 1 AC3 5 PRO A 15 ASP A 16 HOH A 219 HOH A 451 SITE 2 AC3 5 SER B 53 SITE 1 AC4 5 ALA A 70 ARG A 73 HOH A 228 HOH A 495 SITE 2 AC4 5 HOH B 329 SITE 1 AC5 7 HIS A 62 TYR A 99 HOH A 462 HIS B 62 SITE 2 AC5 7 TYR B 99 HIS C 62 TYR C 99 SITE 1 AC6 5 GLY B 68 GLY B 69 ALA B 70 GLN B 71 SITE 2 AC6 5 HOH B 458 SITE 1 AC7 7 LYS A 77 ASP B 16 GLY B 17 PHE B 18 SITE 2 AC7 7 LEU B 19 SER B 20 HOH B 368 SITE 1 AC8 4 GLY C 68 GLY C 69 ALA C 70 GLN C 71 SITE 1 AC9 15 HOH A 424 PRO B 1 MET B 2 LYS B 32 SITE 2 AC9 15 TYR B 36 HIS B 62 SER B 63 ILE B 64 SITE 3 AC9 15 ASP B 92 MET B 101 VAL B 106 PHE B 113 SITE 4 AC9 15 HOH B 283 TYR C 95 ASN C 97 SITE 1 BC1 12 TYR A 95 ASN A 97 PRO C 1 MET C 2 SITE 2 BC1 12 LYS C 32 TYR C 36 HIS C 62 SER C 63 SITE 3 BC1 12 ILE C 64 MET C 101 VAL C 106 PHE C 113 SITE 1 BC2 6 PRO B 1 HIS B 62 SER B 63 TYR C 95 SITE 2 BC2 6 ASN C 97 HOH C 204 SITE 1 BC3 6 ASN A 97 PRO C 1 MET C 2 HIS C 62 SITE 2 BC3 6 SER C 63 ILE C 64 CRYST1 95.595 95.595 103.092 90.00 90.00 120.00 P 31 2 1 18 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010460 0.006039 0.000000 0.00000 SCALE2 0.000000 0.012078 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009700 0.00000